« Previous
Next »
Journal of the Neurological Sciences
Volume 206, Issue 2
, Pages
199-202
, 15 February 2003
Interferon beta 1a for secondary progressive multiple sclerosis
-
SPECTRIMS trial. Kaplan Meier curves for time to confirmed EDSS progression for patients with and without relapses during the 2 years before the study.
SPECTRIMS trial. Kaplan Meier curves for time to confirmed EDSS progression for patients with and without relapses during the 2 years before the study.
☆ Paper presented at European Charcot Meeting Venice October 2001.
PII: S0022-510X(02)00334-9
© 2002 Elsevier Science B.V. All rights reserved.
« Previous
Next »
Journal of the Neurological Sciences
Volume 206, Issue 2
, Pages
199-202
, 15 February 2003
